SSX2 and synovial sarcoma: Significantly, these experiments demonstrated that BRD9 co-purifies with endogenous SS18-SSX containing BAF complexes in synovial sarcoma cells (Figure 2B, Figure 2—source data 1 and 2, Figure 2—figure supplement 1D and Figure 2—figure supplement 1—source data 4).